民生健康
(301507)
| 流通市值：42.53亿 | | | 总市值：42.57亿 |
| 流通股本：3.56亿 | | | 总股本：3.57亿 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 535,359,197.26 | 317,485,567.9 | 781,631,352.96 | 622,651,417.8 |
| 营业收入 | 535,359,197.26 | 317,485,567.9 | 781,631,352.96 | 622,651,417.8 |
| 二、营业总成本 | 433,374,091.8 | 237,413,026.45 | 686,772,522.22 | 527,856,658.74 |
| 营业成本 | 240,027,839.53 | 134,055,835.09 | 382,223,906.91 | 298,329,601.69 |
| 税金及附加 | 5,406,680.45 | 3,665,799.51 | 6,947,157.43 | 5,711,631.6 |
| 销售费用 | 147,178,855.62 | 76,352,886.46 | 215,255,780.53 | 163,207,842.61 |
| 管理费用 | 31,966,857.92 | 16,488,205.57 | 65,287,635.77 | 45,356,652.9 |
| 研发费用 | 12,136,099.82 | 8,665,653.57 | 26,079,557.26 | 22,269,360.7 |
| 财务费用 | -3,342,241.54 | -1,815,353.75 | -9,021,515.68 | -7,018,430.76 |
| 其中:利息费用 | 22,127.38 | 43,221.83 | 56,736.64 | - |
| 其中:利息收入 | 3,454,549.03 | 1,877,512.37 | 9,221,295.02 | 7,172,851.92 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -4,851,506.54 | -4,102,396.04 | 23,878,016.43 | 26,960,798.37 |
| 加:投资收益 | 4,074,933.49 | 1,320,235.57 | 12,874,862.43 | 9,582,086.08 |
| 资产处置收益 | -207,860.26 | -207,860.26 | -3,001.28 | -3,001.28 |
| 资产减值损失(新) | -1,267,424.11 | -640,349.17 | -1,873,435.28 | -1,997,638.55 |
| 信用减值损失(新) | -1,708,027.3 | -1,773,596.53 | 1,353,561.6 | 36,656.46 |
| 其他收益 | 2,204,381.01 | 1,136,734.41 | 6,072,932.8 | 3,349,593.32 |
| 四、营业利润 | 100,229,601.75 | 75,805,309.43 | 137,161,767.44 | 132,723,253.46 |
| 加:营业外收入 | 254,314.51 | 5,805.39 | 467,354.47 | 251,011.82 |
| 减:营业外支出 | 324,566.32 | 11,666.27 | 145,688.33 | 82,462.33 |
| 五、利润总额 | 100,159,349.94 | 75,799,448.55 | 137,483,433.58 | 132,891,802.95 |
| 减:所得税费用 | 16,484,611.96 | 12,836,978.92 | 16,435,971.1 | 17,807,000 |
| 六、净利润 | 83,674,737.98 | 62,962,469.63 | 121,047,462.48 | 115,084,802.95 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 83,674,737.98 | 62,962,469.63 | 121,047,462.48 | 115,084,802.95 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 83,394,343.02 | 62,778,343.85 | 118,791,692.72 | 114,416,514 |
| 少数股东损益 | 280,394.96 | 184,125.78 | 2,255,769.76 | 668,288.95 |
| 扣除非经常损益后的净利润 | 86,225,911.55 | 66,539,232.14 | 92,043,576.13 | 87,969,854.45 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.23 | 0.18 | 0.33 | 0.32 |
| (二)稀释每股收益 | 0.23 | 0.18 | 0.33 | 0.32 |
| 八、其他综合收益 | 4.73 | - | - | - |
| 归属于母公司股东的其他综合收益 | 4.73 | - | - | - |
| 九、综合收益总额 | 83,674,742.71 | 62,962,469.63 | 121,047,462.48 | 115,084,802.95 |
| 归属于母公司股东的综合收益总额 | 83,394,347.75 | 62,778,343.85 | 118,791,692.72 | 114,416,514 |
| 归属于少数股东的综合收益总额 | 280,394.96 | 184,125.78 | 2,255,769.76 | 668,288.95 |
| 公告日期 | 2026-08-28 | 2026-04-24 | 2026-04-24 | 2025-10-30 |
| 审计意见(境内) | | | 标准无保留意见 | |